Contrast Media-Induced Nephropathy and Nephrogenic Systemic Fibrosis

2014 ◽  
pp. 825-837
Author(s):  
Fulvio Stacul
Keyword(s):  
Contrast Media ◽  
Nephrogenic Systemic Fibrosis

scholarly journals Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

2013 ◽  
Vol 17 (3) ◽  
pp. 106
Author(s):  
P S Ngoya ◽  
Z Vawda ◽  
J W Lotz
Keyword(s):  
Contrast Media ◽  
Nephrogenic Systemic Fibrosis

scholarly journals Comparison of the 3D-IR - BTFE method and the conventional method in the head MRI contrast

2017 ◽  
Author(s):  
Daisuke Hirahara
Keyword(s):  
Contrast Media ◽  
Conventional Method ◽  
Side Effect ◽  
Nephrogenic Systemic Fibrosis ◽  
Suitable Method ◽  
Imaging Method ◽  
Gadolinium Contrast ◽  
Mri Contrast ◽  
Highly Effective ◽  
The Brain

AbstractMRI using gadolinium contrast media is useful in diagnosis; however, nephrogenic systemic fibrosis is a serious side effect of gadolinium exposure. Moreover, it turns out that gadolinium deposits in the brain. This has escalated the necessity for a suitable method to use gadolinium contrast media. I developed a new imaging method that had excellent contrast. This study examined the usefulness of that new imaging method and found the method is highly effective.

scholarly journals Curriculum for the Management of Contrast Media Reactions, Contrast Induced Nephropathy & Nephrogenic Systemic Fibrosis

MedEdPORTAL ◽  
2013 ◽  
Author(s):  
Puneet Bhargava ◽  
Adeel Seyal ◽  
Chandana Lall ◽  
Mariam Moshiri ◽  
Jennifer Schopp ◽  
...  
Keyword(s):  
Contrast Media ◽  
Nephrogenic Systemic Fibrosis ◽  
Contrast Induced Nephropathy

scholarly journals Nephrogenic systemic fibrosis (NSF) and gadolinium-based contrast media

2013 ◽  
Vol 17 (3) ◽  
pp. 106-107
Author(s):  
P.S. Ngoya ◽  
Z Vawda ◽  
J.W Lotz
Keyword(s):  
Renal Failure ◽  
Contrast Media ◽  
Contrast Agents ◽  
Nephrogenic Systemic Fibrosis ◽  
Overwhelming Majority ◽  
Tissue Fibrosis ◽  
Systemic Disorder ◽  
High Doses

Nephrogenic systemic fibrosis (NSF), unknown before March 1997 and first described in 2000, is a systemic disorder characterised by widespread tissue fibrosis. The first known case occurred in 1997, after the use of gadolinium-based contrast agents (GBCAs) at high doses in patients with renal failure had become routine. An overwhelming majority occurred within weeks to months after injection of a GBCA. This note comprises guidelines on the prevention of NSF.

Sign in / Sign up

Export Citation Format

Share Document